arrow
S

Sandrine Cojean

University of Paris-Saclay
H指数:24
被引数:1,579

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Are hydrophilic deep eutectic solvents a potential vehicle for topical delivery of Amphotericin B against cutaneous leishmaniasis? An investigation of physicochemical properties, tolerability and antileishmanial efficacy

亲水性深共晶溶剂是否是局部递送Amphotericin B治疗皮肤利什曼病的潜在载体?对物理化学性质、耐受性及抗利什曼原虫活性的研究

2025-12-040
OAAI
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1; 2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy

以药效团为指导对靶向酪蛋白激酶1的抗利什曼原虫治疗中具有潜力的咪唑并[1; 2-a]吡嗪衍生物进行先导化合物CTN1122的优化设计

2025-08-140
PRE
Assessment of ex vivo antimalarial drug efficacy in African Plasmodium falciparum parasite isolates, 2016–2023: a genotype–phenotype association study

非洲恶性疟原虫分离株体外抗疟药物效力的评估,2016–2023年:一项基因型-表型关联研究

2025-07-090
OA
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition

研究基于咪唑并 [1,2-a] 吡嗪的命中化合物CTN1122的C2调节: 合成,体外抗利什曼蛋白活性,细胞毒性和酪蛋白激酶1抑制

2025-01-060
PRE
Effect of Phlebotomus papatasi on the fitness, infectivity and antimony-resistance phenotype of antimony-resistant Leishmania major Mon-25

Papatatasi对抗锑利什曼原虫主要Mon-25的适应性,传染性和抗锑表型的影响

2024-08-010
OAAI
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes-Hydrazones with Antileishmanial and Antibacterial Activities
2023-07-074
OAAI
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
2021-01-0117
OAAI
A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization

配制成可溶解的微针贴片或阳离子脂质体的TLR9-adjuvanted疫苗可预防皮肤或皮下预防接种后的利什曼病

2020-08-0130
OAAI